Azithromycin reduces systemic inflammation and provides survival benefit in murine model of polymicrobial sepsis
A. Patel, J. Joseph, H. Periasamy, S. Mokale
This study shows that azithromycin combined with ceftriaxone improves survival in a murine sepsis model by reducing inflammation, not by antibacterial effects.
bioRxiv · Apr 18, 2018Pharmacology & Toxicology